David Planchard/oncostream.com
Sep 8, 2025, 09:53
David Planchard Highlights FLAURA2 OS Benefit Discussion at WCLC 2025
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinkedIn:
“It was a great pleasure to share the podium with my colleague and friend Daniel Tan. Great discussion (Presidential symposium) on OS benefit of Osi+ChT in FLAURA2.”
More posts featuring WCLC2025 on OncoDaily.
Read More Highlights from WCLC25 on FLAURA2 trial.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 10:52
Sep 8, 2025, 09:53
Sep 8, 2025, 09:46
Sep 8, 2025, 09:06
Sep 8, 2025, 08:57
Sep 8, 2025, 08:22
Sep 8, 2025, 08:21